» » »

Alternative to Warfarin for Arrhythmia Cary NC

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study. Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity.

Sidney C Smith Jr., MD
(919) 966-5201
130 Mason Farm Rd
Chapel Hill, NC
Business
UNC Cardiology
Specialties
Cardiology

Data Provided by:
Divyang Rambhai Patel, MD
(919) 419-7410
103 Oxford Creek Rd
Cary, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Municipal Med Coll, Gujarat Univ, Ahmedabad, Gujarat, India
Graduation Year: 1986

Data Provided by:
Deepak B Shah, MD
(919) 233-0059
300 Keisler Dr Ste 204
Cary, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Med Coll, Baroda Univ, Baroda, Gujarat, India
Graduation Year: 1979

Data Provided by:
Jeffrey Richard Daw
(919) 851-6901
300 Ashville Ave
Cary, NC
Specialty
Cardiology, Internal Medicine

Data Provided by:
Bruce Warren Usher Jr, MD
(919) 851-6901
300 Ashville Ave Ste 301
Cary, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Med Univ Of Sc Coll Of Med, Charleston Sc 29425
Graduation Year: 1993

Data Provided by:
Shaoshan Wang, MD
(919) 216-1976
103 Hadley Creek Dr
Cary, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Shandong Med Univ, Jinan, Shandong, China
Graduation Year: 1992

Data Provided by:
Radha Goel Kachhy, MD
(919) 862-5100
103 Brook Fryar St
Cary, NC
Specialties
Cardiology
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Priyavadan M Shah, MD
(919) 233-0059
300 Keisler Dr Ste 204
Cary, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Med Coll, Baroda Univ, Baroda, Gujarat, India
Graduation Year: 1972

Data Provided by:
Rafael M Moreschi, MD
(919) 467-2253
105 Kilmayne Dr Ste B
Cary, NC
Specialties
Internal Medicine, Cardiovascular Diseases
Gender
Male
Education
Medical School: Univ Nac De Asuncion, Fac De Cien Med, Asuncion, Paraguay
Graduation Year: 1972
Hospital
Hospital: Rex Healthcare, Raleigh, Nc

Data Provided by:
Bruce Warren Usher
(919) 851-6901
300 Ashville Ave
Cary, NC
Specialty
Cardiology

Data Provided by:
Data Provided by:

Alternative to Warfarin for Arrhythmia

Provided By:

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study.

Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity. More than 90 percent of atrial blood clots in people with non-valvular atrial fibrillation may originate in the LAA, according to background information in the study.

The study included 463 people who underwent percutaneous implantation of a device, known as the Watchman, to close off the LAA. Their outcomes were compared with those of 244 people who continued long-term treatment with warfarin.

The researchers determined the effectiveness of the treatments by assessing the occurrence, during an average follow-up of 18 months, of strokes, death from cardiovascular causes and systemic embolisms (blood clots that go somewhere other than the brain). They also totaled the occurrence of such serious problems as major bleeding, pericardial effusion (accidental puncture of the heart causing fluid collection in the heart sac) and clots caused by the implanted device.

After 1,065 patient-years of follow-up, there were 3.0 such occurrences per 100 patient-years among those who'd had the device implanted, compared with 4.9 in the warfarin group, for a risk reduction of 38 percent. But people in the device group had more serious safety events -- 7.4 events per 100 patient-years versus 4.4 events in the warfarin group, the researchers found.

"The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy," concluded Dr. David R. Holmes, of the Mayo Clinic in Rochester, Minn., and his colleagues. "Although there was a higher rate of adverse safety events in the intervention group than the control group, events in the intervention group were mainly a result of periprocedural complications," they wrote.

"Closure of the LAA might provide an alternative strategy to chronic warfarin therapy for stroke prophylaxis in patients with non-valvular atrial fibrillation," they added.

The study appears this week in The Lancet.

More information

The American Academy of Family Physicians has more about atrial fibrillation.

SOURCE: The Lancet, news release, Aug. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com